Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Arbutus hit hard as new hep B drug fails on safety

Shares have fallen sharply since company reported results

#LucidLife is just about to get better with the move to Middlesex House

With only a few weeks to go Jan Steele, Lucid co-founder and COO discusses how the move to Middlesex House supports its commitment to making Lucid a great place to...

Lucid Group Communications Limited

- PMLiVE

Sarepta rival NS Pharma files Duchenne drug with FDA

Another blow for Sarepta following FDA rejection earlier this year

- PMLiVE

UK bans some drug exports to preserve NHS stocks

Insists the move is not related to Brexit

- PMLiVE

Novartis’ Cosentyx scores again in phase 3, strengthens approval claim

Scopes approval in non-radiographic axial spondyloarthritis

- PMLiVE

The business case for patient engagement

Using digital to bridge the engagement gap between patients and pharma

- PMLiVE

NICE turns down Roche’s Tecentriq for triple-negative breast cancer

Will also not be included in the Cancer Drugs Fund

- PMLiVE

Healthcare comms network GLOBALHealthPR welcomes Italian agency Connexia

Addition of Connexia bolsters network's presence in Europe

- PMLiVE

Experiential Marketing

Picture the most amazing day of your life.

Page & Page Health

AstraZeneca AZ

AstraZeneca sells Losec rights as part of refocus strategy

Funds will be diverted to bolster main therapy areas

- PMLiVE

Johnson & Johnson agrees $20.4m settlement in Ohio over opioid crisis

Will avoid upcoming federal trial as a result

- PMLiVE

Biogen’s R&D chief Ehlers heads for the exit

Follows multiple late-stage Alzheimer's study failures

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links